PHIO

#4754
Phio Pharmaceuticals Corp. Common Stock
1.2850 USD
-0.39%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.2850
1.2850
Rango anual
0.9780
1.3500
Cambio diario
-0.39%
Variación mensual
+6.20%
Variación en los últimos 6 meses
+7.98%
Cambio anual
+7.98%
Cierres anteriores
1.2900
Abrir
1.2850
Bid
Ask
Mínimo
1.2850
High
1.2850
Volumen
3
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Noticias